Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Jun. 30, 2019
Jun. 24, 2018
Operating Activities:    
Net income (loss) $ 3,880 $ (4,451)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 1,051 1,165
Income tax provision in excess of income tax payments 2,206 4,958
Non-cash portion of share-based compensation expense 698 659
Net gains on marketable securities and other investments (340) (101)
Indefinite and long-lived asset impairment charges 203 96
Impairment losses on marketable securities and other investments 111 40
Other items, net (207) (46)
Changes in assets and liabilities:    
Accounts receivable, net 1,451 470
Inventories (95) 245
Other assets 15 72
Trade accounts payable (267) (296)
Payroll, benefits and other liabilities (2,534) 1,698
Unearned revenues (113) (178)
Net cash provided by operating activities 6,059 4,331
Investing Activities:    
Capital expenditures (570) (625)
Purchases of debt and equity marketable securities 0 (5,835)
Proceeds from sales and maturities of debt and equity marketable securities 124 9,105
Acquisitions and other investments, net of cash acquired (185) (192)
Proceeds from other investments 45 207
Other items, net 117 (45)
Net cash (used) provided by investing activities (469) 2,615
Financing Activities:    
Proceeds from short-term debt 4,808 9,385
Repayment of short-term debt (4,813) (7,198)
Repayment of long-term debt 0 (1,571)
Proceeds from issuance of common stock 264 387
Repurchases and retirements of common stock (1,088) (1,425)
Dividends paid (2,257) (2,600)
Payments of tax withholdings related to vesting of share-based awards (225) (273)
Payment of purchase consideration related to RF360 joint venture (44) (157)
Other items, net (91) (54)
Net cash used by financing activities (3,446) (3,506)
Effect of exchange rate changes on cash and cash equivalents 2 (19)
Net increase in total cash and cash equivalents 2,146 3,421
Total cash and cash equivalents at beginning of period 11,777 37,029
Total cash and cash equivalents at end of period 13,923 40,450
Cash and cash equivalents 13,923 35,619
Restricted cash and restricted cash equivalents included in other assets $ 0 $ 4,831